• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

US MHRA extends portal access for adverse vaxx and meds reporting

Roehl_JC

Moderator
MHRA extend swine flu adverse drug reaction portal
12 November, 2009

The MHRA have extended the swine flu adverse drug reaction (ADR) portal to include swine flu vaccines and seasonal vaccines.


In July 2009 the MHRA launched a special swine flu ADR portal for reporting suspected adverse drug reaction to oseltamivir (Tamiflu) and zanamivir (Relenza).

The MHRA now have extended use of this portal to include suspected ADRs to new swine flu vaccines and seasonal vaccines.

Reports should include;

the patient?s age;
a description of the suspected adverse reaction and outcome;
any underlying risk factors.

Click here for further information.

http://www.nursingtimes.net/whats-n...-adverse-drug-reaction-portal/5008490.article
 
Back
Top